Hydrastine

Hydrastine
Clinical data
ATC code	none;
Pharmacokinetic data
Metabolism	Hepatic
Excretion	Renal
Identifiers
	IUPAC name 6,7-Dimethoxy-3-(6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one;
CAS Number	118-08-1 ;
PubChem CID	197835;
ChemSpider	171234 ;
UNII	8890V3217X;
ChEMBL	ChEMBL497942 ;
CompTox Dashboard (EPA)	DTXSID9025409 ;
ECHA InfoCard	100.003.849
Chemical and physical data
Formula	C21H21NO6
Molar mass	383.400 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	132 °C (270 °F)
	SMILES O=C2O[C@@H](c1ccc(OC)c(OC)c12)[C@@H]5N(C)CCc4c5cc3OCOc3c4;
	InChI InChI=1S/C21H21NO6/c1-22-7-6-11-8-15-16(27-10-26-15)9-13(11)18(22)19-12-4-5-14(24-2)20(25-3)17(12)21(23)28-19/h4-5,8-9,18-19H,6-7,10H2,1-3H3/t18-,19+/m1/s1 ; Key:JZUTXVTYJDCMDU-MOPGFXCFSA-N ;
	(what is this?) (verify)

Hydrastine is an isoquinoline alkaloid which was discovered in 1851 by Alfred P. Durand. Hydrolysis of hydrastine yields hydrastinine, which was patented by Bayer as a haemostatic drug during the 1910s. It is present in Hydrastis canadensis (thus the name) and other plants of the family Ranunculaceae.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.